Skip to main content

Day: February 13, 2023

Dental Endoscopes Market is Predicted to Garner a Revenue of USD 1,200.00 Million by Growing with a CAGR of 11.7% During 2022-2028; Growing Demand for Advanced Dental Diagnosis and Therapy Evaluation to Accelerate Market Growth – SkyQuest

The most recent study conducted by SkyQuest on the dental endoscopes market is based on the compilation, evaluation, and interpretation of information from reliable and highly trustworthy sources. The primary goals of the study report are to forecast the trends that will be popular in the upcoming years as well as to estimate the sizes of the major categories and areas. For the purpose of determining the company scope, the study report also includes qualitative and quantitative data for each key regional market. Westford, USA, Feb. 13, 2023 (GLOBE NEWSWIRE) — The dental endoscopes market in the North America region to gain the highest market share during the projected time frame. On the basis of the rising aging population and the rising frequency of dental implants, the market is anticipated to experience notable expansion. The...

Continue reading

EuroDry Ltd. Reports Results for the Year and Quarter Ended December 31, 2022

ATHENS, Greece, Feb. 13, 2023 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and twelve-month periods ended December 31, 2022. Fourth Quarter 2022 Highlights:Total net revenues of $15.1 million.Net income attributable to common shareholders of $6.3 million or $2.21 and $2.20 earnings per share basic and diluted, respectively.Adjusted net income attributable to common shareholders1 for the quarter of $3.3 million, or, $1.18 per share basic and diluted, respectively.Adjusted EBITDA1 was $7.3 million.An average of 10.1 vessels were owned and operated during the fourth quarter of 2022 earning an average time charter equivalent rate of $16,689 per day....

Continue reading

San Cristobal Mining Inc. Completes Acquisition of Minera San Cristobal S.A.

VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) — San Cristobal Mining Inc. (“San Cristobal Mining” or “SCM” or the “Company”) is pleased to announce that it has completed the acquisition of Minera San Cristóbal S.A. (“MSC”) and all of its associated assets from Sumitomo Corporation (“Sumitomo”) under the terms of a stock purchase agreement pursuant to which the Company acquired all the issued and outstanding shares of Comercial Metales Blancos AB, SC Minerals Bolivia S.R.L., former subsidiaries of Sumitomo which hold all of the equity interests in MSC (the “Transaction“). Quinton Hennigh, President and Director of San Cristobal Mining, stated: “We are excited to complete our acquisition of Minera San Cristóbal S.A. and all of its associated assets and subsidiaries, bringing San Cristobal Mining into the...

Continue reading

Aleafia Health Announces Q3 FY2023 Results, International Expansion and Second Quarter of Profitability

2nd consecutive quarter of positive Adjusted EBITDA1 4% Adjusted EBITDA margin2 places company in top 3 position for profitability amongst its peers3 9% growth in adult use revenue4 over prior quarter; 5% growth in adult-use revenue5year over year 40% increase in medical net revenue6 with $1.1 million record month revenue in November 2022 1st shipment made toward new European agreement announced in Q2 FY2023 Estimated $1 million sales7 contract to second European partner Gross profit before fair value adjustments of 37% versus 27% in the prior year8TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its financial results for the three months ended December 31, 2022, its third quarter of its fiscal year ending March 31, 2023 (“FY2023”). For...

Continue reading

mdf commerce reports Third Quarter of Fiscal 2023 Financial Results

Q3 FY2023 total revenue of $31.7 million grew by 3.3% compared to $30.7 million in Q3 FY2022 Recurring Revenue (1)of $24.7 million in Q3 FY2023 compared to $25.0 million in Q3 FY2022 Adjusted EBITDA(2) of $0.9 million for Q3 FY2023 compared to $0.7 million in Q3 FY2022 Sale of InterTrade subsidiary for cash proceeds of $65.8 million and repayment of the majority of long-term debtMONTREAL, Feb. 13, 2023 (GLOBE NEWSWIRE) — mdf commerce inc. (the “Corporation”) (TSX:MDF), a SaaS leader in digital commerce technologies, reported third quarter financial results for the three-month period ended December 31, 2022 (Q3 FY2023). Financial references are expressed in Canadian dollars unless otherwise indicated. “This third quarter of fiscal 2023 represents a second consecutive quarter with a positive adjusted EBITDA(2). In response to...

Continue reading

Pyxis Oncology to Participate in the Virtual 2023 SVB Securities Global Biopharma Conference

CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, Pamela Connealy, Chief Financial Officer, Jay Feingold, M.D., Ph.D., Chief Medical Officer, and Jan Pinkas, Ph.D., Chief Scientific Officer, will host investor meetings on February 15, 2023 as part of the SVB Securities Global Biopharma Conference, taking place virtually. Institutional investors interested in meeting with management during the conference may reach out to their SVB Securities representative or Jennifer Davis Ruff, Investor Relations for Pyxis Oncology, at jdavisruff@pyxisoncology.com.         About Pyxis Oncology, Inc.Pyxis Oncology,...

Continue reading

Freshpet, Inc. to Report Fourth Quarter and Fiscal 2022 Results on Monday, February 27, 2023

SECAUCUS, N.J., Feb. 13, 2023 (GLOBE NEWSWIRE) — Freshpet, Inc. (NASDAQ: FRPT) (“Freshpet” or the “Company”) today announced it will report results for the fourth quarter and fiscal year ended December 31, 2022 on Monday, February 27, 2023 before market open. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 8:00 a.m. ET on Monday, February 27, 2023. To participate on the live call, listeners in North America may dial (877) 407-0792 and international listeners may dial (201) 689-8263. In addition, the call will be broadcast live over the Internet, hosted at the “Investor” section of the Company’s website at www.freshpet.com and will be archived online. A telephonic playback will be...

Continue reading

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial Results

SAN DIEGO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company will host a conference call and live audio webcast on Tuesday, February 28, 2023 at 5:00 PM ET to report its fourth quarter and full year 2022 financial results and provide a corporate update. In order to participate in the conference call, please register using the conference link here. The live webcast can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast...

Continue reading

Enphase Energy and Lumio Expand Solar Technology Leadership Across the United States

FREMONT, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that Lumio, a leader in personalized renewable energy, will significantly expand its offering of Enphase® IQ8™ Microinverters and IQ™ Batteries to customers across the United States. Enphase® Energy Systems with IQ Batteries and the revolutionary IQ8 Microinverters, the industry’s first microgrid-forming microinverters launched late last year, offer homeowners even greater resilience than ever before. The strategic relationship with Lumio will amplify the impact and distribution of Enphase Energy Systems — providing homeowners more access to reliable, sustainable, and grid-independent power...

Continue reading

SmileDirectClub Introduces CarePlus Premium Aligner Offering

New service gives customers even more choice with expanded ways to get started and manage aligner care in-person or remotely NASHVILLE, Tenn., Feb. 13, 2023 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the oral care company with the first medtech platform for teeth straightening, today announced the launch of its new premium aligner treatment, CarePlus. Available now at select Partner Network dentist locations, CarePlus delivers a higher touch, tech-forward option in orthodontic care with greater flexibility and choice through a combination of both in-person and virtual patient management, value added services, and concierge-level care from SmileDirectClub’s network of licensed dentists, orthodontists, hygienists, and dental assistants. ​ To get started, CarePlus customers visit a participating Partner Network dental...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.